ExecPay

Keith Regnante

Overview20212020

Overview

Keith Regnante received an average of $3M in total compensation, including $362K in salary, at Keros Therapeutics between 2020 and 2021.

Source: SEC filings on April 18, 2022 and April 19, 2021.
Regnante's 2021 pay

Related executives

We found four more executives who work or worked at Keros Therapeutics.

Jasbir Seehra

Keros Therapeutics

Chief Executive Officer

4

Christopher Rovaldi

Keros Therapeutics

Chief Operating Officer

1

Simon MBBS

Keros Therapeutics

Chief Medical Officer

1

Jennifer Lachey

Keros Therapeutics

Chief Scientific Officer

3

News

You may also like

Keros Therapeutics